XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
As Previously Reported [Member]
Common Stock [Member]
Common Stock [Member]
As Previously Reported [Member]
Capital in Excess of Par Value [Member]
Capital in Excess of Par Value [Member]
As Previously Reported [Member]
Retained Earnings [Member]
Retained Earnings [Member]
As Previously Reported [Member]
Accumulated Other Comprehensive Earnings (Loss) [Member]
Accumulated Other Comprehensive Earnings (Loss) [Member]
As Previously Reported [Member]
Noncontrolling Interests [Member]
Noncontrolling Interests [Member]
As Previously Reported [Member]
Beginning Balance at Dec. 31, 2017   $ 4,164.9   $ 181.0   $ 3,388.2   $ 1,095.9   $ (559.9)   $ 59.7
Beginning Balance (in shares) at Dec. 31, 2017     181.0 181.0                
Adoption of Topic 606 (Accounting Standards Update 2014-09 [Member]) at Dec. 31, 2017 $ 134.8           $ 125.9   $ 4.5   $ 4.4  
Beginning Balance, as restated at Dec. 31, 2017 4,299.7   $ 181.0   $ 3,388.2   1,221.8   (555.4)   64.1  
Reclassification of the income tax effects within accumulated other comprehensive loss related to the Tax Act             6.6   (6.6)      
Net earnings 286.0           273.7       12.3  
Dividends paid to noncontrolling interests (8.7)                   (8.7)  
Net change in pension asset/liability, net of taxes 7.0               7.0      
Foreign currency translation 64.5               62.3   2.2  
Change in fair value of derivative instruments, net of taxes (6.8)               (6.8)      
Compensation expense related to stock option plan grants 4.8       4.8              
Common stock issued in: purchase transactions 6.5   $ 0.1   6.4              
Common stock issued in: purchase transactions (in shares)     0.1                  
Stock option plans 28.2   $ 0.8   27.4              
Stock option plans (in shares)     0.8                  
Employee stock purchase plan 4.1   $ 0.1   4.0              
Employee stock purchase plan (in shares)     0.1                  
Deferred compensation and restricted stock (14.1)   $ 0.2   (14.3)              
Deferred compensation and restricted stock (in shares)     0.2                  
Common stock repurchases (11.3)   $ (0.1)   (11.2)              
Common stock repurchases (in shares)     (0.1)                  
Cash dividends declared on common stock (75.4)           (75.4)          
Ending Balance at Mar. 31, 2018 4,584.5   $ 182.1   3,405.3   1,426.7   (499.5)   69.9  
Ending Balance (in shares) at Mar. 31, 2018     182.1                  
Beginning Balance at Dec. 31, 2018 4,569.7   $ 184.0   3,541.9   1,558.6   (785.6)   70.8  
Beginning Balance (in shares) at Dec. 31, 2018     184.0                  
Adoption of Topic 606 (Accounting Standards Update 2014-09 [Member]) at Dec. 31, 2018 (2.4)           (2.2)   (0.2)      
Net earnings 351.7           334.1       17.6  
Net purchase of subsidiary shares from noncontrolling interests (0.3)       (0.2)           (0.1)  
Dividends paid to noncontrolling interests (11.0)                   (11.0)  
Net change in pension asset/liability, net of taxes 1.6               1.6      
Foreign currency translation 75.1               74.5   0.6  
Change in fair value of derivative instruments, net of taxes (11.8)               (11.8)      
Compensation expense related to stock option plan grants 3.6       3.6              
Common stock issued in: purchase transactions 37.0   $ 0.5   36.5              
Common stock issued in: purchase transactions (in shares)     0.5                  
Stock option plans $ 28.1   $ 0.7   27.4              
Stock option plans (in shares) 0.7   0.7                  
Employee stock purchase plan $ 4.7   $ 0.1   4.6              
Employee stock purchase plan (in shares)     0.1                  
Deferred compensation and restricted stock (7.5)       (7.5)              
Cash dividends declared on common stock (80.3)           (80.3)          
Ending Balance at Mar. 31, 2019 $ 4,958.2   $ 185.3   $ 3,606.3   $ 1,810.2   $ (721.5)   $ 77.9  
Ending Balance (in shares) at Mar. 31, 2019     185.3